Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ota

Showing results (31-40 of 151) with videos related to

Pageof 16
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 10, 1991
[Diagnosis and therapy of adult Still's disease]M Yamaguchi, A Ota
Hybridoma|September 4, 1999
Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cellsA Ota, S Ueda
Microbios|January 1, 1988
ATPase activity in cells of the yeast Saccharomycopsis fibuligera during mycelial growthA Ota, H Morishita
Hybridoma|November 26, 1999
Analysis of the anti-HIV-1 activity of an anti-p17-derivative peptide (P30-52) monoclonal antibodyA Ota, S Ueda
The International Journal of Biochemistry|January 1, 1988
Characterization of ATPase activity in the mycelial form cells of yeast Saccharomycopsis fibuligeraA Ota, H Morishita
The Journal of Pharmacy and Pharmacology|September 1, 1999
Cultured rabbit corneal epithelium elicits levofloxacin absorption and secretionK Kawazu, Y Midori, A Ota
Chemical & Pharmaceutical Bulletin|March 1, 1996
Quantitative structure-activity relationships of Ca(2+)-antagonistic semotiadil congenersK Fujimura, A Ota, Y Kawashima
Biochemical and Biophysical Research Communications|August 24, 1995
Deletion mutagenesis of human tyrosine hydroxylase type 1 regulatory domainA Ota, S Yoshida, T Nagatsu
Chemical & Pharmaceutical Bulletin|May 1, 1993
Synthesis of thiazolidine-2-thione derivatives and evaluation of their hepatoprotective effectsK Yoneda, A Ota, Y Kawashima
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 10, 1996
[Progress on diagnosis and therapy of diabetic gangrene]N Saito, M Nishikawa, A Ota
Pageof 16

Showing results (31-40 of 151) with videos related to

Sort By:
Pageof 16
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 10, 1991
[Diagnosis and therapy of adult Still's disease]M Yamaguchi, A Ota
Hybridoma|September 4, 1999
Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cellsA Ota, S Ueda
Microbios|January 1, 1988
ATPase activity in cells of the yeast Saccharomycopsis fibuligera during mycelial growthA Ota, H Morishita
Hybridoma|November 26, 1999
Analysis of the anti-HIV-1 activity of an anti-p17-derivative peptide (P30-52) monoclonal antibodyA Ota, S Ueda
The International Journal of Biochemistry|January 1, 1988
Characterization of ATPase activity in the mycelial form cells of yeast Saccharomycopsis fibuligeraA Ota, H Morishita
The Journal of Pharmacy and Pharmacology|September 1, 1999
Cultured rabbit corneal epithelium elicits levofloxacin absorption and secretionK Kawazu, Y Midori, A Ota
Chemical & Pharmaceutical Bulletin|March 1, 1996
Quantitative structure-activity relationships of Ca(2+)-antagonistic semotiadil congenersK Fujimura, A Ota, Y Kawashima
Biochemical and Biophysical Research Communications|August 24, 1995
Deletion mutagenesis of human tyrosine hydroxylase type 1 regulatory domainA Ota, S Yoshida, T Nagatsu
Chemical & Pharmaceutical Bulletin|May 1, 1993
Synthesis of thiazolidine-2-thione derivatives and evaluation of their hepatoprotective effectsK Yoneda, A Ota, Y Kawashima
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 10, 1996
[Progress on diagnosis and therapy of diabetic gangrene]N Saito, M Nishikawa, A Ota
Pageof 16